These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32851890)

  • 21. The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.
    Azrak RG; Frank CL; Ling X; Slocum HK; Li F; Foster BA; Rustum YM
    Mol Cancer Ther; 2006 Oct; 5(10):2540-8. PubMed ID: 17041098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase.
    Konrad RJ; Zhang F; Hale JE; Knierman MD; Becker GW; Kudlow JE
    Biochem Biophys Res Commun; 2002 Apr; 293(1):207-12. PubMed ID: 12054585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic apoptosis by combination of metformin and an O-GlcNAcylation inhibitor in colon cancer cells.
    Lee DE; Lee GY; Lee HM; Choi SY; Lee SJ; Kwon OS
    Cancer Cell Int; 2023 Jun; 23(1):108. PubMed ID: 37268905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. O-GlcNAcylation modulates HBV replication through regulating cellular autophagy at multiple levels.
    Wang X; Lin Y; Liu S; Zhu Y; Lu K; Broering R; Lu M
    FASEB J; 2020 Nov; 34(11):14473-14489. PubMed ID: 32892442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
    Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
    Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-Assembling Derivative of Hydrocortisone as Glucocorticoid Receptor-Targeted Nanotherapeutics for Synergistic, Combination Therapy against Colorectal Tumor.
    Sridharan K; Rathore B; Yousuf M; Reddy Rachamalla HK; Jinka S; Jaggarapu MMCS; Banerjee R
    Mol Pharm; 2021 Mar; 18(3):1208-1228. PubMed ID: 33371687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro.
    Budman DR; Calabro A; Kreis W
    Anticancer Drugs; 2002 Nov; 13(10):1011-6. PubMed ID: 12439335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.
    Barkovskaya A; Seip K; Hilmarsdottir B; Maelandsmo GM; Moestue SA; Itkonen HM
    Sci Rep; 2019 Apr; 9(1):5670. PubMed ID: 30952976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells.
    Tolba MF; Esmat A; Al-Abd AM; Azab SS; Khalifa AE; Mosli HA; Abdel-Rahman SZ; Abdel-Naim AB
    IUBMB Life; 2013 Aug; 65(8):716-29. PubMed ID: 23847086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines.
    Kapadia GJ; Rao GS; Ramachandran C; Iida A; Suzuki N; Tokuda H
    J Complement Integr Med; 2013 Jun; 10():. PubMed ID: 23828331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
    Badinloo M; Esmaeili-Mahani S
    Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baicalin and Baicalein Enhance Cytotoxicity, Proapoptotic Activity, and Genotoxicity of Doxorubicin and Docetaxel in MCF-7 Breast Cancer Cells.
    Bernasinska-Slomczewska J; Hikisz P; Pieniazek A; Koceva-Chyla A
    Molecules; 2024 May; 29(11):. PubMed ID: 38893380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.
    Awasthi N; Schwarz MA; Schwarz RE
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):571-82. PubMed ID: 21110024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (Adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancer cell lines.
    Kapadia GJ; Azuine MA; Rao GS; Arai T; Iida A; Tokuda H
    Anticancer Agents Med Chem; 2011 Mar; 11(3):280-4. PubMed ID: 21434853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. γ-Tocotrienol and α-Tocopherol Ether Acetate Enhance Docetaxel Activity in Drug-Resistant Prostate Cancer Cells.
    Asay S; Graham A; Hollingsworth S; Barnes B; Oblad RV; Michaelis DJ; Kenealey JD
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31963634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone.
    Kalantzis ED; Scorilas A; Vassilacopoulou D
    Curr Pharm Biotechnol; 2018; 19(13):1087-1096. PubMed ID: 30417785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.